An Abbott Laboratories offshoot is planning to sell more than $10 billion of new bonds next week, in part to fund its coming split, according to people familiar with the proposed debt sale. A deal of that size would put the offering in the 10-largest U.S.
FULL ARTICLE AT Asian Wall Street Journal